Your browser doesn't support javascript.
loading
Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment.
Gergely, Tamás G; Kucsera, Dániel; Tóth, Viktória E; Kovács, Tamás; Sayour, Nabil V; Drobni, Zsófia D; Ruppert, Mihály; Petrovich, Balázs; Ágg, Bence; Onódi, Zsófia; Fekete, Nóra; Pállinger, Éva; Buzás, Edit I; Yousif, Laura I; Meijers, Wouter C; Radovits, Tamás; Merkely, Béla; Ferdinandy, Péter; Varga, Zoltán V.
Afiliación
  • Gergely TG; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Kucsera D; HCEMM-SE Cardiometabolic Immunology Research Group, Semmelweis University, Budapest, Hungary.
  • Tóth VE; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group, Semmelweis University, Budapest, Hungary.
  • Kovács T; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Sayour NV; HCEMM-SE Cardiometabolic Immunology Research Group, Semmelweis University, Budapest, Hungary.
  • Drobni ZD; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group, Semmelweis University, Budapest, Hungary.
  • Ruppert M; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Petrovich B; HCEMM-SE Cardiometabolic Immunology Research Group, Semmelweis University, Budapest, Hungary.
  • Ágg B; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group, Semmelweis University, Budapest, Hungary.
  • Onódi Z; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Fekete N; HCEMM-SE Cardiometabolic Immunology Research Group, Semmelweis University, Budapest, Hungary.
  • Pállinger É; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group, Semmelweis University, Budapest, Hungary.
  • Buzás EI; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Yousif LI; HCEMM-SE Cardiometabolic Immunology Research Group, Semmelweis University, Budapest, Hungary.
  • Meijers WC; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group, Semmelweis University, Budapest, Hungary.
  • Radovits T; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Ferdinandy P; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Varga ZV; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
Br J Pharmacol ; 180(6): 740-761, 2023 03.
Article en En | MEDLINE | ID: mdl-36356191
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Cardiotoxicidad / Cardiopatías Límite: Animals Idioma: En Revista: Br J Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Cardiotoxicidad / Cardiopatías Límite: Animals Idioma: En Revista: Br J Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Hungria